We validated the predicted number of drug-sensitive and drug-resistant tumor cells in a conditional transgenic mouse model of MYC-driven T-cell acute lymphoblastic leukemia (T-ALL) in which MYC expression can be controlled temporally through the tetracycline-regulated system (Tet system)3. Here, MYC is linked to T-cell acute lymphoblastic leukemia.